Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Cronenberger C"'
Autor:
Dagenais S; Real World Evidence Platform, Pfizer, Inc., New York, NY, USA., Lee C; Internal Medicine Research Unit, Pfizer, Inc., New York, NY, USA., Cronenberger C; Clinical Pharmacology & Bioanalytics, Pfizer, Inc., New York, NY, USA., Wang E; Clinical Pharmacology & Bioanalytics, Pfizer, Inc., New York, NY, USA., Sahasrabudhe V; Clinical Pharmacology & Bioanalytics, Pfizer, Inc., New York, NY, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13741.
Autor:
Fleischmann RM; University of Texas Southwestern Medical Center, Metroplex Clinical Research Center, Dallas, TX, USA. Electronic address: rfleischmann@dfwra.com., Saikali W; Rheumatology and Pulmonary Clinic, Beckley, WV, USA., Lakhanpal S; University of Texas Southwestern Medical Center, Dallas, TX, USA., Alvarez DF; Pfizer, Collegeville, PA, USA., Cox DS; Pfizer, Collegeville, PA, USA., Ianos CA; Pfizer Zürich, Switzerland., Zhang W; Pfizer, Lake Forest, IL, USA., Cronenberger C; Pfizer, Collegeville, PA, USA., Wang K; Pfizer, La Jolla, CA, USA.
Publikováno v:
The Lancet. Rheumatology [Lancet Rheumatol] 2023 Sep; Vol. 5 (9), pp. e532-e541. Date of Electronic Publication: 2023 Aug 21.
Objective; This extension study provided continued treatment to subjects with active rheumatoid arthritis who had participated for ≥16 weeks in a pharmacokinetic similarity study of PF‐05280586 (potential rituximab biosimilar). Objectives were to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::dc4f70d60462c1bd2a888c47d844bb45
https://eprints.whiterose.ac.uk/129983/40/Cohen_et_al-2018-Arthritis_Care_%26_Research.pdf
https://eprints.whiterose.ac.uk/129983/40/Cohen_et_al-2018-Arthritis_Care_%26_Research.pdf
Autor:
Fleischmann RM; University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, Dallas, TX, USA. rfleischmann@arthdocs.com., Bock AE; Pfizer Inc, Cambridge, MA, USA., Zhang W; Pfizer Inc, Lake Forest, IL, USA., Godfrey CM; Pfizer R&D UK Ltd, Cambridge, UK., Vranic I; Pfizer, Tadworth, UK., Cronenberger C; Pfizer Inc, Collegeville, PA, USA., Dokoupilová E; Medical Plus, s.r.o., Uherske Hradiste, Czech Republic.; Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic.
Publikováno v:
Rheumatology and therapy [Rheumatol Ther] 2022 Jun; Vol. 9 (3), pp. 839-850. Date of Electronic Publication: 2022 Mar 18.
Autor:
Fleischmann RM; University of Texas Southwestern Medical Center at Dallas, Metroplex Clinical Research Center, Dallas, TX, USA. RFleischmann@arthdocs.com., Alvarez DF; Pfizer Inc., Collegeville, PA, USA., Bock AE; Pfizer Inc., Cambridge, MA, USA., Cronenberger C; Pfizer Inc., Collegeville, PA, USA., Vranic I; Pfizer, Tadworth, UK., Zhang W; Pfizer Inc., Lake Forest, IL, USA., Alten R; Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2021 Sep 25; Vol. 23 (1), pp. 248. Date of Electronic Publication: 2021 Sep 25.
Autor:
Fleischmann RM; Metroplex Clinical Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA rfleischmann@arthdocs.com., Alvarez DF; Global Product Development, Inflammation and Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA., Bock AE; Global Product Development, Clinical Development and Operations, Pfizer Inc, Cambridge, Massachusetts, USA., Cronenberger C; Global Product Development, Inflammation and Immunology, Pfizer Inc, Collegeville, Pennsylvania, USA., Vranic I; Worldwide R&D, Safety Surveillance Risk Management, Pfizer Inc, Tadworth, UK., Zhang W; Global Product Development, Biometrics and Data Management, Pfizer Inc, Lake Forest, Illinois, USA., Alten R; University Medicine, Schlosspark Klinik, Berlin, Germany.
Publikováno v:
RMD open [RMD Open] 2021 Apr; Vol. 7 (2).
Autor:
Santos, Luisa Oliveira1 (AUTHOR) santos.luisa@ufba.br, Alves, Izabel Almeida1 (AUTHOR), Azeredo, Francine Johansson2 (AUTHOR) francinej@ufl.edu
Publikováno v:
Pharmaceutics. Sep2024, Vol. 16 Issue 9, p1124. 15p.
Autor:
Anfinogenova, Nina D.1 (AUTHOR) cardio.intl@gmail.com, Stepanov, Vadim A.2 (AUTHOR), Chernyavsky, Alexander M.3 (AUTHOR), Karpov, Rostislav S.1 (AUTHOR), Efimova, Elena V.1 (AUTHOR), Novikova, Oksana M.1 (AUTHOR), Trubacheva, Irina A.1 (AUTHOR), Falkovskaya, Alla Y.1 (AUTHOR), Maksimova, Aleksandra S.1 (AUTHOR), Ryumshina, Nadezhda I.1 (AUTHOR), Shelkovnikova, Tatiana A.1 (AUTHOR), Ussov, Wladimir Y.1,3 (AUTHOR), Vaizova, Olga E.4 (AUTHOR), Popov, Sergey V.1 (AUTHOR), Repin, Alexei N.1 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 15, p4289. 21p.
Autor:
Srivastava, Anshika1, Tiwari, Kshama2 ktkshamatiwari@gmail.com, Irfan, Sumaiya3, Zaidi, Noorin4, Ahmad, Sharique4, Mehdi, Syed Riaz4
Publikováno v:
Asian Journal of Medical Sciences. Aug2024, Vol. 15 Issue 8, p140-150. 11p.
Autor:
Alvarez DF; Inflammation and Immunology, Pfizer Inc, 500 Arcola Rd, Collegeville, PA, 19426, USA. Daniel.F.Alvarez@pfizer.com., Wolbink G; University of Amsterdam, Amsterdam, The Netherlands., Cronenberger C; Clinical Pharmacology, Pfizer Inc, Collegeville, PA, USA., Orazem J; Global Biostatistics and Data Management, Pfizer Inc, New York, NY, USA., Kay J; Departments of Medicine and of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.; Department of Medicine, UMass Memorial Medical Center, Worcester, MA, USA.
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2020 Dec; Vol. 34 (6), pp. 723-732.